Transcranial pulsed electromagnetic fields for multiple chemical sensitivity: study protocol for a randomized, double-blind, placebo-controlled trial

Marie Thi Dao Tran, Sine Skovbjerg, Lars Arendt-Nielsen, Karl Bang Christensen, Jesper Elberling, Marie Thi Dao Tran, Sine Skovbjerg, Lars Arendt-Nielsen, Karl Bang Christensen, Jesper Elberling

Abstract

Background: Multiple chemical sensitivity (MCS) is a chronic condition of unknown etiology. MCS is characterized by recurrent nonspecific symptoms from multiple organ systems in response to chemical exposures in concentrations that are normally tolerated by the majority of the population. The symptoms may have severe impact on patients' lives, but an evidence-based treatment for the condition is nonexisting. The pathophysiology is unclarified, but several indicators point towards abnormal processing of sensory signals in the central nervous system. Pulsed electromagnetic fields (PEMF) offer a promising new treatment for refractory depression and can be targeted at the brain, thereby activating biochemical cell processes.

Methods/design: In a parallel, randomized, double-blind, placebo-controlled trial conducted at the Danish Research Centre for Chemical Sensitivities, the effects of PEMF in MCS patients will be assessed using the Re5 Independent System. Based on sample size estimation, 40 participants will be randomized to either PEMF therapy or placebo. The allocation sequence will be generated by computer. All involved parties (that is, participants, investigators, the research nurse, and the statistician) will be blinded to group allocation. The participants will receive PEMF therapy or placebo applied transcranially 30 minutes twice a day for 7 days a week over 6 consecutive weeks. Outcomes will be measured at baseline, once weekly during treatment, post treatment, and at 2.5-month and 4.5-month follow-up according to a predefined timetable. The primary outcome will be a measurement of the impact of MCS on everyday life. The secondary outcomes will be measurements of MCS symptoms, psychological distress (stress, anxiety or depressive symptoms), capsaicin-induced secondary punctate hyperalgesia, immunological markers in serum, and quality of life.

Discussion: This trial will assess the effects of PEMF therapy for MCS. Currently, there is no treatment with a documented effect on MCS, and in terms of healthcare there is very little to offer these patients. There is thus a great need for well-conducted randomized trials aimed at assessing possible treatment effects. A positive outcome will pave the way for improved healthcare and understanding of this very disabling and overlooked condition.

Trial registration: ClinicalTrials.gov, NCT01834781.

References

    1. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999;54:147–149.
    1. Cullen MR. The worker with multiple chemical sensitivities: an overview. Occup Med. 1987;2:655–661.
    1. Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: a systematic review of provocation studies. J Allergy Clin Immunol. 2006;118:1257–1264. doi: 10.1016/j.jaci.2006.07.046.
    1. Labarge XS, McCaffrey RJ. Multiple chemical sensitivity: a review of the theoretical and research literature. Neuropsychol Rev. 2000;10:183–211. doi: 10.1023/A:1026460726965.
    1. Caress SM, Steinemann AC, Waddick C. Symptomatology and etiology of multiple chemical sensitivities in the south-eastern United States. Arch Environ Health. 2002;57:429–436. doi: 10.1080/00039890209601433.
    1. Koch L, Rumrill P, Hennessey M, Vierstra C, Roessler RT. An ecological approach to facilitate successful employment outcomes among people with multiple chemical sensitivity. Work. 2007;29:341–349.
    1. Graveling RA, Pilkington A, George JP, Butler MP, Tannahill SN. A review of multiple chemical sensitivity. Occup Environ Med. 1999;56:73–85. doi: 10.1136/oem.56.2.73.
    1. Rainville P, Bushnell MC, Duncan GH. Representation of acute and persistent pain in the human CNS: potential implications for chemical intolerance. Ann N Y Acad Sci. 2001;933:130–141.
    1. Read D. Multiple Chemical Sensitivities. Wellington, New Zealand: Environmental Risk Management Authority; 2002. pp. 1–49.
    1. Winder C. Mechanisms of multiple chemical sensitivity. Toxicol Lett. 2002;128:85–97. doi: 10.1016/S0378-4274(01)00536-7.
    1. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36:339–356. doi: 10.1016/j.semarthrit.2006.12.009.
    1. Bailer J, Witthoft M, Bayerl C, Rist F. Syndrome stability and psychological predictors of symptom severity in idiopathic environmental intolerance and somatoform disorders. Psychol Med. 2007;37:271–281. doi: 10.1017/S0033291706009354.
    1. Bailer J, Witthoft M, Rist F. Psychological predictors of short- and medium term outcome in individuals with idiopathic environmental intolerance (IEI) and individuals with somatoform disorders. J Toxicol Environ Health A. 2008;71:766–775. doi: 10.1080/15287390801985562.
    1. Eek F, Karlson B, Osterberg K, Ostergren PO. Factors associated with prospective development of environmental annoyance. J Psychosom Res. 2010;69:9–15. doi: 10.1016/j.jpsychores.2009.12.001.
    1. Osterberg K, Persson R, Karlson B, Carlsson EF, Orbaek P. Personality, mental distress, and subjective health complaints among persons with environmental annoyance. Hum Exp Toxicol. 2007;26:231–241. doi: 10.1177/0960327107070575.
    1. Skovbjerg S, Zachariae R, Rasmussen A, Johansen JD, Elberling J. Attention to bodily sensations and symptom perception in individuals with idiopathic environmental intolerance. Environ Health Prev Med. 2010;15:141–150. doi: 10.1007/s12199-009-0120-y.
    1. Skovbjerg S, Zachariae R, Rasmussen A, Johansen JD, Elberling J. Repressive coping and alexithymia in idiopathic environmental intolerance. Environ Health Prev Med. 2010;15:299–310. doi: 10.1007/s12199-010-0143-4.
    1. Hillert L, Musabasic V, Berglund H, Ciumas C, Savic I. Odor processing in multiple chemical sensitivity. Hum Brain Mapp. 2007;28:172–182. doi: 10.1002/hbm.20266.
    1. Orriols R, Costa R, Cuberas G, Jacas C, Castell J, Sunyer J. Brain dysfunction in multiple chemical sensitivity. J Neurol Sci. 2009;287:72–78. doi: 10.1016/j.jns.2009.09.003.
    1. Holst H, Arendt-Nielsen L, Mosbech H, Elberling J. Increased capsaicin-induced secondary hyperalgesia in patients with multiple chemical sensitivity. Clin J Pain. 2011;27:156–162. doi: 10.1097/AJP.0b013e3181f9d60c.
    1. Tran MT, Arendt-Nielsen L, Kupers R, Elberling J. Multiple chemical sensitivity: on the scent of central sensitization. Int J Hyg Environ Health. 2013;216:202–210. doi: 10.1016/j.ijheh.2012.02.010.
    1. Sorg BA. Multiple chemical sensitivity: potential role for neural sensitization. Crit Rev Neurobiol. 1999;13:283–316.
    1. De Luca C, Scordo MG, Cesareo E, Pastore S, Mariani S, Maiani G, Stancato A, Loreti B, Valacchi G, Lubrano C, Raskovic D, De Padova L, Genovesi G, Korkina LG. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. Toxicol Appl Pharmacol. 2010;248:285–292. doi: 10.1016/j.taap.2010.04.017.
    1. Sampalli T, Berlasso E, Fox R, Petter M. A controlled study of the effect of a mindfulness-based stress reduction technique in women with multiple chemical sensitivity, chronic fatigue syndrome, and fibromyalgia. J Multidiscip Healthc. 2009;2:53–59.
    1. Skovbjerg S, Hauge CR, Rasmussen A, Winkel P, Elberling J. Mindfulness-based cognitive therapy to treat multiple chemical sensitivities: a randomized pilot trial. Scand J Psychol. 2012;53:233–238. doi: 10.1111/j.1467-9450.2012.00950.x.
    1. Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: review. Curr Opin Otolaryngol Head Neck Surg. 2007;15:274–280. doi: 10.1097/MOO.0b013e328259c360.
    1. Elberling J, Gulmann N, Rasmussen A. Electroconvulsive therapy substantially reduces symptom severity and social disability associated with multiple chemical sensitivity: a case report. J ECT. 2010;26:231–233. doi: 10.1097/YCT.0b013e3181cad75b.
    1. Rahbek UL, Tritsaris K, Dissing S. Interactions of Low-frequency, pulsed electromagnetic fields with living tissue: biochemical responses and clinical results. Oral Biosci Med. 2005;2:29–40.
    1. Bassett CA, Pilla AA, Pawluk RJ. A non-operative salvage of surgically-resistant pseudarthroses and non-unions by pulsing electromagnetic fields. A preliminary report. Clin Orthop Relat Res. 1977;124:128–143.
    1. Longo FM, Yang T, Hamilton S, Hyde JF, Walker J, Jennes L, Stach R, Sisken BF. Electromagnetic fields influence NGF activity and levels following sciatic nerve transection. J Neurosci Res. 1999;55:230–237. doi: 10.1002/(SICI)1097-4547(19990115)55:2<230::AID-JNR10>;2-3.
    1. Macias MY, Battocletti JH, Sutton CH, Pintar FA, Maiman DJ. Directed and enhanced neurite growth with pulsed magnetic field stimulation. Bioelectromagnetics. 2000;21:272–286. doi: 10.1002/(SICI)1521-186X(200005)21:4<272::AID-BEM4>;2-5.
    1. Sisken BF, Kanje M, Lundborg G, Herbst E, Kurtz W. Stimulation of rat sciatic nerve regeneration with pulsed electromagnetic fields. Brain Res. 1989;485:309–316. doi: 10.1016/0006-8993(89)90575-1.
    1. Kim SS, Shin HJ, Eom DW, Huh JR, Woo Y, Kim H, Ryu SH, Suh PG, Kim MJ, Kim JY, Koo TW, Cho YH, Chung SM. Enhanced expression of neuronal nitric oxide synthase and phospholipase C-γ1 in regenerating murine neuronal cells by pulsed electromagnetic field. Exp Mol Med. 2002;34:53–59. doi: 10.1038/emm.2002.8.
    1. Hogan MV, Wieraszko A. An increase in cAMP concentration in mouse hippocampal slices exposed to low-frequency and pulsed magnetic fields. Neurosci Lett. 2004;366:43–47. doi: 10.1016/j.neulet.2004.05.006.
    1. Patino O, Grana D, Bolgiani A, Prezzavento G, Mino J, Merlo A, Benaim F. Pulsed electromagnetic fields in experimental cutaneous wound healing in rats. J Burn Care Rehabil. 1996;17:528–531. doi: 10.1097/00004630-199611000-00009.
    1. Pezzetti F, De MM, Caruso A, Cadossi R, Zucchini P, Carinci F, Traina GC, Sollazzo V. Effects of pulsed electromagnetic fields on human chondrocytes: an in vitro study. Calcif Tissue Int. 1999;65:396–401. doi: 10.1007/s002239900720.
    1. Tepper OM, Callaghan MJ, Chang EI, Galiano RD, Bhatt KA, Baharestani S, Gan J, Simon B, Hopper RA, Levine JP, Gurtner GC. Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2. FASEB J. 2004;18:1231–1233.
    1. Smith TL, Wong-Gibbons D, Maultsby J. Microcirculatory effects of pulsed electromagnetic fields. J Orthop Res. 2004;22:80–84. doi: 10.1016/S0736-0266(03)00157-8.
    1. Bassett CA, Mitchell SN, Gaston SR. Treatment of ununited tibial diaphyseal fractures with pulsing electromagnetic fields. J Bone Joint Surg Am. 1981;63:511–523.
    1. Thamsborg G, Florescu A, Oturai P, Fallentin E, Tritsaris K, Dissing S. Treatment of knee osteoarthritis with pulsed electromagnetic fields: a randomized, double-blind, placebo-controlled study. Osteoarthritis Cartilage. 2005;13:575–581. doi: 10.1016/j.joca.2005.02.012.
    1. Trock DH, Bollet AJ, Markoll R. The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, double blind, placebo controlled trials. J Rheumatol. 1994;21:1903–1911.
    1. Martiny K, Lunde M, Bech P. Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression. Biol Psychiatry. 2010;68:163–169. doi: 10.1016/j.biopsych.2010.02.017.
    1. Lacour M, Zunder T, Schmidtke K, Vaith P, Scheidt C. Multiple chemical sensitivity syndrome (MCS) – suggestions for an extension of the US MCS-case definition. Int J Hyg Environ Health. 2005;208:141–151. doi: 10.1016/j.ijheh.2005.01.017.
    1. Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B, Luczynska C, Garcia-Esteban R, Burney P, Antó JM. European Community Respiratory Health Survey Study Group. Geographic variations in the effect of atopy on asthma in the European community respiratory health study. J Allergy Clin Immunol. 2004;114:1033–1039. doi: 10.1016/j.jaci.2004.05.072.
    1. Miller CS, Prihoda TJ. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health. 1999;15:370–385.
    1. Skovbjerg S, Berg ND, Elberling J, Christensen KB. Evaluation of the quick environmental exposure and sensitivity inventory in a Danish population. J Environ Publ Health. 2012;2012:304314. Epub 2012 Jan 12.
    1. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95.
    1. Olsen LR, Mortensen EL, Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand. 2004;110:225–229. doi: 10.1111/j.1600-0447.2004.00399.x.
    1. Olsen LR, Mortensen EL, Bech P. Mental distress in the Danish general population. Acta Psychiatr Scand. 2006;113:477–484. doi: 10.1111/j.1600-0447.2005.00743.x.
    1. Hooper CL, Bakish D. An examination of the sensitivity of the six-item Hamilton Rating Scale for depression in a sample of patients suffering from major depressive disorder. J Psychiatry Neurosci. 2000;25:178–184.
    1. Cohen S, Williamson G. The Social Psychology of Health. Newbury Park, CA: Sage; 1988. Perceived stress in a probability sample in the United States; pp. 31–67.
    1. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28:551–558.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere